Treatment of Hyperkalemia
The treatment of hyperkalemia requires immediate intervention with calcium gluconate for cardiac stabilization, followed by insulin with glucose and beta-agonists to shift potassium intracellularly, while simultaneously initiating measures to eliminate potassium from the body. 1
Classification and Assessment
Hyperkalemia is classified into three categories:
- Mild: 5.0-5.5 mmol/L
- Moderate: 5.6-6.5 mmol/L
- Severe: >6.5 mmol/L 1
ECG assessment is crucial, with changes correlating to potassium levels:
- 5.5-6.5 mmol/L: Peaked/tented T waves (early sign)
- 6.5-7.5 mmol/L: Prolonged PR interval, flattened P waves
- 7.0-8.0 mmol/L: Widened QRS, deep S waves
10 mmol/L: Sinusoidal pattern, VF, asystole, or PEA 1
Treatment Algorithm
1. Cardiac Membrane Stabilization (Immediate)
- Calcium gluconate: 10% solution, 15-30 mL IV
2. Intracellular Potassium Shift (15-30 minutes)
- Insulin with glucose: 10 units regular insulin IV with 50 mL of 25% dextrose
- Onset: 15-30 minutes
- Duration: 1-2 hours
- Inhaled beta-agonists: 10-20 mg nebulized over 15 minutes
- Onset: 15-30 minutes
- Duration: 2-4 hours
- Sodium bicarbonate: 50 mEq IV over 5 minutes (less favored due to poor efficacy when used alone)
3. Potassium Elimination (30+ minutes)
- Loop diuretics: 40-80 mg IV (for patients with adequate renal function)
- Onset: 30-60 minutes
- Duration: 2-4 hours
- Potassium binders:
- Hemodialysis: Most effective method for severe or refractory hyperkalemia 1, 6
Treatment Based on Severity
Mild Hyperkalemia (5.0-5.5 mmol/L)
- Consider potassium binders for chronic management
- Adjust medications that affect potassium levels
- Increase monitoring frequency 1
Moderate Hyperkalemia (5.6-6.5 mmol/L)
- Consider all treatments for mild hyperkalemia
- Add insulin with glucose and/or beta-agonists if symptomatic or with ECG changes 1, 7
Severe Hyperkalemia (>6.5 mmol/L)
- Immediate calcium gluconate administration
- Insulin with glucose and beta-agonists
- Consider hemodialysis, especially if refractory to medical therapy 1, 6
Monitoring and Follow-up
- Continuous cardiac monitoring during treatment
- Serial potassium measurements:
- First check: 1-2 hours after initial treatment
- Subsequent checks: every 4-6 hours until stable 1
Important Considerations and Pitfalls
Do not rely solely on ECG changes to determine treatment urgency, as absent or atypical ECG changes do not exclude the need for immediate intervention 3
Avoid potassium-containing fluids such as Lactated Ringer's solution or Hartmann's solution in patients with suspected hyperkalemia 1
Identify and hold medications that can worsen hyperkalemia:
- Renin-angiotensin-aldosterone system inhibitors (RAASi)
- Mineralocorticoid receptor antagonists (MRAs)
- Potassium-sparing diuretics 1
Be aware of rebound hyperkalemia after initial treatment, especially when transcellular shifts are involved 7
Sodium Polystyrene Sulfonate (SPS) should not be used for emergency treatment of life-threatening hyperkalemia due to its delayed onset of action 4
More aggressive management may be required for patients with heart failure, chronic kidney disease, or diabetes mellitus, even for potassium levels in the high-normal range (>5.0 mmol/L) 1